X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
100
PharmaCompass offers a list of Clindamycin Palmitate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clindamycin Palmitate manufacturer or Clindamycin Palmitate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clindamycin Palmitate manufacturer or Clindamycin Palmitate supplier.
PharmaCompass also assists you with knowing the Clindamycin Palmitate API Price utilized in the formulation of products. Clindamycin Palmitate API Price is not always fixed or binding as the Clindamycin Palmitate Price is obtained through a variety of data sources. The Clindamycin Palmitate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clindamycin Palmitate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clindamycin Palmitate, including repackagers and relabelers. The FDA regulates Clindamycin Palmitate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clindamycin Palmitate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clindamycin Palmitate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clindamycin Palmitate supplier is an individual or a company that provides Clindamycin Palmitate active pharmaceutical ingredient (API) or Clindamycin Palmitate finished formulations upon request. The Clindamycin Palmitate suppliers may include Clindamycin Palmitate API manufacturers, exporters, distributors and traders.
click here to find a list of Clindamycin Palmitate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clindamycin Palmitate DMF (Drug Master File) is a document detailing the whole manufacturing process of Clindamycin Palmitate active pharmaceutical ingredient (API) in detail. Different forms of Clindamycin Palmitate DMFs exist exist since differing nations have different regulations, such as Clindamycin Palmitate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clindamycin Palmitate DMF submitted to regulatory agencies in the US is known as a USDMF. Clindamycin Palmitate USDMF includes data on Clindamycin Palmitate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clindamycin Palmitate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clindamycin Palmitate suppliers with USDMF on PharmaCompass.
A Clindamycin Palmitate written confirmation (Clindamycin Palmitate WC) is an official document issued by a regulatory agency to a Clindamycin Palmitate manufacturer, verifying that the manufacturing facility of a Clindamycin Palmitate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clindamycin Palmitate APIs or Clindamycin Palmitate finished pharmaceutical products to another nation, regulatory agencies frequently require a Clindamycin Palmitate WC (written confirmation) as part of the regulatory process.
click here to find a list of Clindamycin Palmitate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clindamycin Palmitate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clindamycin Palmitate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clindamycin Palmitate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clindamycin Palmitate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clindamycin Palmitate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clindamycin Palmitate suppliers with NDC on PharmaCompass.
Clindamycin Palmitate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clindamycin Palmitate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clindamycin Palmitate GMP manufacturer or Clindamycin Palmitate GMP API supplier for your needs.
A Clindamycin Palmitate CoA (Certificate of Analysis) is a formal document that attests to Clindamycin Palmitate's compliance with Clindamycin Palmitate specifications and serves as a tool for batch-level quality control.
Clindamycin Palmitate CoA mostly includes findings from lab analyses of a specific batch. For each Clindamycin Palmitate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clindamycin Palmitate may be tested according to a variety of international standards, such as European Pharmacopoeia (Clindamycin Palmitate EP), Clindamycin Palmitate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clindamycin Palmitate USP).
Market Place
